ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

February 19, 1982

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

CCOP Discussion Dominate ACCC Annual Meeting

March 12, 1982

Pressure On Reagan To Appoint Scientists to NCAB Increases with Demand From Powerful Congressman

March 9, 1984

Funding Opportunities Listed.

January 14, 2005